- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Opinion
Video
Vitiligo Insights: Case-Based Discussion on Delayed Treatment, Psychosocial Impact, and Evolving Approaches for SOC Patients
Author(s):
Panelists discuss how vitiligo treatment delays, psychosocial effects, and emerging therapies impact standard of care for patients through case-based analysis.
Video Player is loading.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Prioritizing Rapid Itch Relief in a 58-Year-Old Patient With Severe Prurigo Nodularis
Challenges With Topical Psoriasis Treatments and the Need for Simpler Options
Personalizing Psoriasis Treatment and Site-of-Care Decisions
Exploring the Impact of Itch and Treatment Advances in Prurigo Nodularis
Sustaining Repigmentation in Vitiligo Requires Gradual Step-Down Approach, Says Gina Mangin, MPAS, PA-C
Approaches to Personalizing Systemic Treatment in Atopic Dermatitis
The Clinical Impact of Atopic Dermatitis: Burden, Age-Related Differences, and Unmet Needs
Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management
Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice
Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments
Related Content
